PGIM Jennison Health Sciences Fund - Class A (PHLAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
32.63
-0.37 (-1.12%)
Jul 11, 2025, 4:00 PM EDT
-20.51%
Fund Assets 1.34B
Expense Ratio 1.13%
Min. Investment $1,000
Turnover 79.00%
Dividend (ttm) 5.31
Dividend Yield 15.22%
Dividend Growth 177.71%
Payout Frequency Annual
Ex-Dividend Date n/a
Previous Close 33.00
YTD Return -2.83%
1-Year Return 1.65%
5-Year Return 51.13%
52-Week Low 29.55
52-Week High 43.93
Beta (5Y) n/a
Holdings 45
Inception Date Jun 30, 1999

About PHLAX

PGIM Jennison Health Sciences Fund Class A is a mutual fund focused on long-term capital appreciation by investing primarily in equity and equity-related securities of U.S. companies within the healthcare sector. The fund targets firms engaged in pharmaceuticals, biotechnology, medical equipment, hospitals, nursing care, and health insurance carriers. With assets totaling approximately $1.68 billion and an expense ratio of about 1.13%, it offers exposure to a diversified portfolio of around 46 holdings, including prominent healthcare companies such as Eli Lilly, UnitedHealth Group, and Bristol-Myers Squibb. Since its inception in 1999, the fund has sought to leverage healthcare innovation and growth trends to deliver value, making it a specialized vehicle within the health sciences investment space. The fund pays dividends annually and maintains a focus on large growth companies in the health sector.

Fund Family PGIM Investments
Category Health
Stock Exchange NASDAQ
Ticker Symbol PHLAX
Share Class Class A
Index S&P Composite 1500 Health Care TR

Performance

PHLAX had a total return of 1.65% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.75%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
PHLQX Class R6 0.77%
PHSZX Class Z 0.86%
PJHRX Class R 1.48%
PHLCX Class C 1.96%

Top 10 Holdings

57.84% of assets
Name Symbol Weight
Eli Lilly and Company LLY 14.60%
Prudential Govt Money Mkt Fd n/a 10.96%
Vertex Pharmaceuticals Incorporated VRTX 4.95%
argenx SE ARGX 4.85%
Neurocrine Biosciences, Inc. NBIX 4.78%
AstraZeneca PLC AZN 4.64%
Thermo Fisher Scientific Inc. TMO 3.58%
Novo Nordisk A/S NVO 3.50%
Alnylam Pharmaceuticals, Inc. ALNY 3.15%
UnitedHealth Group Incorporated UNH 2.85%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 20, 2024 $5.31325 Dec 20, 2024
Dec 20, 2023 $1.91322 Dec 20, 2023
Dec 20, 2022 $0.61624 Dec 20, 2022
Dec 20, 2021 $14.02528 Dec 20, 2021
Dec 20, 2019 $1.43164 Dec 20, 2019
Dec 20, 2018 $4.77761 Dec 20, 2018
Full Dividend History